EGEN (Pharmaceuticals) is Pharmaceuticals in United States that focus on Acid Interference business. Founded in 2002. They cover business area such as Provider, therapeutic nucleic acid, protein, specific disease, Deoxyribo Nucleic Acid, (DNA, Ribonucleic Acid Interference (RNAi) delivery, human disease, cancer, cardiovascular disease.
2002
( 22 years old in 2024 )
Acid Interference
-
601 Genome Way Northwest
Suite 3100
Huntsville, AL 35806
United States
Private
Providertherapeutic nucleic acidproteinspecific diseaseDeoxyribo Nucleic Acid(DNARibonucleic Acid Interference (RNAi) deliveryhuman diseasecancercardiovascular disease
* We use standard office opening hours in near EGEN (Pharmaceuticals)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EGEN (Pharmaceuticals) is Pharmaceuticals business from United States that founded in 2002 (22 years old in 2024), EGEN (Pharmaceuticals) business is focusing on Acid Interference.
EGEN (Pharmaceuticals) headquarter office and corporate office address is located in 601 Genome Way Northwest Suite 3100 Huntsville, AL 35806 United States.
EGEN (Pharmaceuticals) was founded in United States.
In 2024, EGEN (Pharmaceuticals) is currently focus on Acid Interference sector.
Above is snippet of Google Trends for "Acid Interference" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EGEN (Pharmaceuticals), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
